AMA Journal of Ethics^®

This article applies principlism to what a “shoppable service” model would demand of clinicians in practice.

Dr Sherry Glied joins Ethics Talk to discuss her article, coauthored with Grace Kim: “Which Price Should Be Transparent and Why?”

Fragmentation in US health care delivery streams and shortcomings in formal quality measures mean that transparency could be more useful to policymakers and regulators than patients.

Dr Kevin Schulman joins Ethics Talk to discuss his article, coauthored with Dr Barak Richman: “Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm.”

Dr Rajani Katta joins Ethics Talk to discuss her article, coauthored with Dina H. Zamil, Emily K. Burns, and Dr Ariadna Perez-Sanchez: “Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements?”

Jorie Braunold joins Ethics Talk to discuss her article: “How Long Have Supplements Promised to Make Us Slim, Sexy, and Virile?”

Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky.

Dietary supplements can have side effects; interact with medications, food, or other supplements; or be unsafe.

Dr Amy B. Cadwallader, Joshua J. Klein, and Scott J. Schweikart join this episode of Ethics Talk to discuss safety and limited legal means of reining in social media influencers' advertisements about dietary supplements.

Elizabeth Richardson joins Ethics Talk to discuss her article, coauthored Farzana Akkas and Dr Amy B. Cadwallader: “What Should Dietary Supplement Oversight Look Like in the US?”